Eugene Johnston - Peoplesway CoFounder Director
| PLWY Stock | USD 0.0001 0.00 0.00% |
Director
Eugene Johnston is CoFounder Director of peoplesway
| Age | 60 |
| Address | 2969 Interstate Street, Charlotte, NC, United States, 28208 |
| Phone | 866-762-7599 |
| Web | https://www.peoplesway.com |
Eugene Johnston Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eugene Johnston against Peoplesway stock is an integral part of due diligence when investing in Peoplesway. Eugene Johnston insider activity provides valuable insight into whether Peoplesway is net buyers or sellers over its current business cycle. Note, Peoplesway insiders must abide by specific rules, including filing SEC forms every time they buy or sell Peoplesway'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eugene Johnston over two weeks ago Acquisition by Eugene Johnston of 25000 shares of Mangoceuticals, Common subject to Rule 16b-3 |
Peoplesway Management Efficiency
The company has return on total asset (ROA) of 0.1985 % which means that it generated a profit of $0.1985 on every $100 spent on assets. This is way below average. Peoplesway's management efficiency ratios could be used to measure how well Peoplesway manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -3.02 in 2024. Return On Capital Employed is likely to drop to -0.76 in 2024. At this time, Peoplesway's Total Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 122.6 K in 2024, despite the fact that Net Tangible Assets are likely to grow to (1.2 M).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Joanne Smith | AptarGroup | 59 | |
| William Feehery | West Pharmaceutical Services | 50 | |
| Paula Johnson | West Pharmaceutical Services | 59 | |
| Giovanna Monnas | AptarGroup | 65 | |
| Stuart Randle | Teleflex Incorporated | 61 | |
| Jody Lindell | The Cooper Companies, | 69 | |
| Myla LaiGoldman | West Pharmaceutical Services | 62 | |
| Richard Packer | Teleflex Incorporated | 62 | |
| Kim Duncan | The Cooper Companies, | N/A | |
| Claire Pomeroy | Becton Dickinson and | 65 | |
| Catherine Burzik | Becton Dickinson and | 70 | |
| Rebecca Rimel | Becton Dickinson and | 69 | |
| Jesse Wu | AptarGroup | 62 | |
| Colleen Jay | The Cooper Companies, | 58 | |
| Andreas Kramvis | AptarGroup | 68 | |
| Bertram Scott | Becton Dickinson and | 69 | |
| Andrew Krakauer | Teleflex Incorporated | 66 | |
| Carol Burt | ResMed Inc | 62 | |
| Douglas Michels | West Pharmaceutical Services | 63 | |
| William Kozy | The Cooper Companies, | 69 | |
| Marshall Larsen | Becton Dickinson and | 72 | |
Management Performance
peoplesway Leadership Team
Elected by the shareholders, the Peoplesway's board of directors comprises two types of representatives: Peoplesway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Peoplesway. The board's role is to monitor Peoplesway's management team and ensure that shareholders' interests are well served. Peoplesway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Peoplesway's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eugene Johnston, CoFounder Director | ||
| Christie Yerby, Product Board | ||
| Ken Monroe, Business Advisor | ||
| Matthew Monroe, President CoFounder |
Peoplesway Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Peoplesway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.2 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 900.29 K | ||||
| Price To Earning | 0.02 X | ||||
| Price To Sales | 0.88 X | ||||
| Revenue | 373.16 K | ||||
| Gross Profit | 606.05 K | ||||
| EBITDA | 39.08 K | ||||
| Net Income | (63.34 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Peoplesway Stock Analysis
When running Peoplesway's price analysis, check to measure Peoplesway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Peoplesway is operating at the current time. Most of Peoplesway's value examination focuses on studying past and present price action to predict the probability of Peoplesway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Peoplesway's price. Additionally, you may evaluate how the addition of Peoplesway to your portfolios can decrease your overall portfolio volatility.